Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-01

Clinical Trial Update: Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol Targets [NA]

View source ↗

Summary

A completed clinical trial evaluated adding ezetimibe to ongoing rosuvastatin therapy in HIV-positive patients not reaching cholesterol targets; results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CRESTOR (Rosuvastatin)
  • Ezetrol (ezetimibe)

Snippet

Sponsor: University of British Columbia | Conditions: Hypercholesterolemia, HIV Infections | NA | Status: COMPLETED | Results posted: 2016-01-01